The document describes an Active School Flag site visit hosted by Irish CHRODIS+ partners in Dublin, Ireland. The two-day visit aimed to demonstrate and share learning from Ireland's Active School Flag initiative, which promotes physical activity in schools. The agenda included background information on the initiative, demonstrations of how it works in five schools, and discussions of research and lessons learned in implementing the program in Irish primary schools.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 21st Congress of the European Association of Dental Public Health (1 October 2016 Budapest)
This presentation is part of the report presented by the WHO Regional Director Zsuzsanna Jakab at the 63rd session of the WHO Regional Committee for Europe in Çeşme Izmir, Turkey, on 16 September 2013.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the School of Public Health Management (Chisinau, Republic of Moldova, 24 November 2016)
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the Advanced Training and Conference on Health Economics (24 June 2015, Budapest, Hungary)
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting on Interdepartmental Plan for Public Health of Catalonia (PINSAP) Strategy and Programme, held in Barcelona, Spain on 14 February 2014.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
Electronic registry for the management of childhood obesity in GreecePanagiotis Papaioannou
Obesity in childhood and adolescence represents a major health problem in our century. In Greece, more than 30%-35% of children and adolescents are either overweight or obese.
Using information and communication technologies, we developed a "National Registry for the Prevention and Management of Overweight and Obesity in Childhood and Adolescence" for guidance and training of Pediatricians and General Practitioners. The application supports interoperability with other national infrastructures and multi-layered security spanning preventive, detective and administrative controls. The Patient Summary Dataset includes information on medical history, family history, medications, immunizations, clinical examination and laboratory findings and appointment booking service.
AUTHORS:
Penio Kassari, Panagiotis Papaioannou, Antonis Billiris, Haralampos Karanikas, Stergiani Eleftheriou, Eleftherios Thireos, Yannis Manios, George P Chrousos, Evangelia Charmandari
Compared with its European neighbours, France has been slower to stake out a more aggressive policy for combatting obesity. In part, this is a simple question of numbers: around 15% of the country’s adult population was obese in 2014, well below the levels seen in England (24.8%), Germany (23.6%) or Spain (22.9%).
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe at
Scientific conference: crossroad of policy, research, education and practice in primary health care
23 October 2018, Almaty, Kazakhstan
European Union Action in the field of Rare Diseases. Antoni Monserrat Moliner. Presentation of the Strategy in Rare Diseases of the National Health System. (Madrid, Ministry of Health and Social Politics, 2009).
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting "Health in Action reforming the Greek National Health System to Improve Citizens’ Health", on 5 March 2014, Athens, Greece.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the Advanced Training and Conference on Health Economics (24 June 2015, Budapest, Hungary)
Contemporary health policy context in Europe: some opportunities and challenges
Presentation by Dr Zsuzsanna Jakab, WHO Regional Director for Europe. 8 March 2017, Israel
Presentation made by Zsuzsanna Jakab, WHO Regional Director for Europe, at the meeting on Interdepartmental Plan for Public Health of Catalonia (PINSAP) Strategy and Programme, held in Barcelona, Spain on 14 February 2014.
Presentation delivered by Dr Zsuzsanna Jakab, WHO Regional Director for Europe, at the 67th session of the WHO Regional Committee for Europe (Budapest, Hungary, 11–14 September 2017)
Electronic registry for the management of childhood obesity in GreecePanagiotis Papaioannou
Obesity in childhood and adolescence represents a major health problem in our century. In Greece, more than 30%-35% of children and adolescents are either overweight or obese.
Using information and communication technologies, we developed a "National Registry for the Prevention and Management of Overweight and Obesity in Childhood and Adolescence" for guidance and training of Pediatricians and General Practitioners. The application supports interoperability with other national infrastructures and multi-layered security spanning preventive, detective and administrative controls. The Patient Summary Dataset includes information on medical history, family history, medications, immunizations, clinical examination and laboratory findings and appointment booking service.
AUTHORS:
Penio Kassari, Panagiotis Papaioannou, Antonis Billiris, Haralampos Karanikas, Stergiani Eleftheriou, Eleftherios Thireos, Yannis Manios, George P Chrousos, Evangelia Charmandari
Compared with its European neighbours, France has been slower to stake out a more aggressive policy for combatting obesity. In part, this is a simple question of numbers: around 15% of the country’s adult population was obese in 2014, well below the levels seen in England (24.8%), Germany (23.6%) or Spain (22.9%).
By Dr Zsuzsanna Jakab, WHO Regional Director for Europe at
Scientific conference: crossroad of policy, research, education and practice in primary health care
23 October 2018, Almaty, Kazakhstan
European Union Action in the field of Rare Diseases. Antoni Monserrat Moliner. Presentation of the Strategy in Rare Diseases of the National Health System. (Madrid, Ministry of Health and Social Politics, 2009).
EUPATI Status Update at EMA PCWP Meeting, 26 Nov 2015jangeissler
Overview and Status Quo of the European Patients Academy (EUPATI) project, presented by EUPATI Director Jan Geissler at the EMA Patient and Consumer Working Party (PCWP) meeting in London on 26 Nov 2015
Presented at the 66th session of the WHO Regional Committee for Europe by Dr Claudia Stein, Director,
Information, Evidence, Research and Innovation, WHO/Europe
Respiratory Diseases in European Health Priorities during the Polish Presiden...Global Risk Forum GRFDavos
GRF One Health Summit 2012, Davos: Presentation by Dr. Monika Przygucka-Gawlik - Councellor of the Minister - Department of Public Health - Ministry of Health - Poland
EN EN COMMISSION OF THE EUROPEAN COMMUNITIES Br.docxSALU18
EN EN
COMMISSION OF THE EUROPEAN COMMUNITIES
Brussels, 23.10.2007
COM(2007) 630 final
WHITE PAPER
Together for Health:
A Strategic Approach for the EU 2008-2013
(presented by the Commission)
{SEC(2007) 1374}
{SEC(2007) 1375}
{SEC(2007) 1376}
EN 2 EN
WHITE PAPER
Together for Health:
A Strategic Approach for the EU 2008-2013
1. WHY A NEW HEALTH STRATEGY?
Health is central in people's lives and needs to be supported by effective policies and actions
in Member States, at EC1 level and at global level.
Member States have the main responsibility for health policy and provision of healthcare to
European citizens. The EC's role is not to mirror or duplicate their work. However, there are
areas where Member States cannot act alone effectively and where cooperative action at
Community level is indispensable. These include major health threats and issues with a cross-
border or international impact, such as pandemics and bioterrorism, as well as those relating
to free movement of goods, services and people.
To carry out this role, cross-sectoral work is required. Article 152 of the EC Treaty says that a
"high level of human health protection shall be ensured in the definition and implementation
of all Community policies and activities". This Strategy reinforces the importance of health in
policies such as the Lisbon Strategy for Growth and Jobs, emphasising the links between
health and economic prosperity, and the Citizens' Agenda, recognising people's right to be
empowered in relation to their health and healthcare. Actions in the Strategy represent work
on health across all sectors. Health is found in Treaty articles on the Internal Market,
Environment, Consumer Protection, Social Affairs including the Safety and Health of
Workers, Development Policy, and Research, amongst many others2.
The EC's important role in health policy has been reaffirmed in the Reform Treaty which was
agreed by EU Heads of State and Government in Lisbon on 19 October 2007, and which
proposes to reinforce the political importance of health. A new overall aim on supporting
citizens' wellbeing is expected, as well as an encouragement of cooperation amongst Member
States on health and health services. Work on health at Community level adds value to
Member States' actions, particularly in the area of prevention of illness, including work on
food safety and nutrition, the safety of medical products, tackling smoking, legislation on
blood, tissues and cells, and organs, water and air quality, and the launch of a number of
health-related agencies. However, there are several growing challenges to the health of the
population which require a new strategic approach.
– Firstly, demographic changes including population ageing are changing disease patterns
and putting pressure on the sustainability of EU health systems. Supporting healthy ageing
means both promoting health throughout the lifespan, aiming to prevent h ...
Presented by Hans Kluge, Director, Division of Health Systems and Public Health, WHO/Europe at the 64th session of the WHO Regional Committee for Europe, on 16 September 2014.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
This document is designed as an introductory to medical students,nursing students,midwives or other healthcare trainees to improve their understanding about how health system in Sri Lanka cares children health.
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardso...rightmanforbloodline
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
TEST BANK For Accounting Information Systems, 3rd Edition by Vernon Richardson, Verified Chapters 1 - 18, Complete Newest Version
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
KEY Points of Leicester travel clinic In London doc.docxNX Healthcare
In order to protect visitors' safety and wellbeing, Travel Clinic Leicester offers a wide range of travel-related health treatments, including individualized counseling and vaccines. Our team of medical experts specializes in getting people ready for international travel, with a particular emphasis on vaccines and health consultations to prevent travel-related illnesses. We provide a range of travel-related services, such as health concerns unique to a trip, prevention of malaria, and travel-related medical supplies. Our clinic is dedicated to providing top-notch care, keeping abreast of the most recent recommendations for vaccinations and travel health precautions. The goal of Travel Clinic Leicester is to keep you safe and well-rested no matter what kind of travel you choose—business, pleasure, or adventure.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
We are one of the top Massage Spa Ajman Our highly skilled, experienced, and certified massage therapists from different corners of the world are committed to serving you with a soothing and relaxing experience. Luxuriate yourself at our spas in Sharjah and Ajman, which are indeed enriched with an ambiance of relaxation and tranquility. We could confidently claim that we are one of the most affordable Spa Ajman and Sharjah as well, where you can book the massage session of your choice for just 99 AED at any time as we are open 24 hours a day, 7 days a week.
Visit : https://massagespaajman.com/
Call : 052 987 1315
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDr Rachana Gujar
Introduction: Substance use education is crucial due to its prevalence and societal impact.
Alcohol Use: Immediate and long-term risks include impaired judgment, health issues, and social consequences.
Tobacco Use: Immediate effects include increased heart rate, while long-term risks encompass cancer and heart disease.
Drug Use: Risks vary depending on the drug type, including health and psychological implications.
Prevention Strategies: Education, healthy coping mechanisms, community support, and policies are vital in preventing substance use.
Harm Reduction Strategies: Safe use practices, medication-assisted treatment, and naloxone availability aim to reduce harm.
Seeking Help for Addiction: Recognizing signs, available treatments, support systems, and resources are essential for recovery.
Personal Stories: Real stories of recovery emphasize hope and resilience.
Interactive Q&A: Engage the audience and encourage discussion.
Conclusion: Recap key points and emphasize the importance of awareness, prevention, and seeking help.
Resources: Provide contact information and links for further support.
Under Pressure : Kenneth Kruk's StrategyKenneth Kruk
Kenneth Kruk's story of transforming challenges into opportunities by leading successful medical record transitions and bridging scientific knowledge gaps during COVID-19.
1. @EU_CHRODISplus chrodis.eu
Co-funded
by the Third Health Programme
of the European Union
EU_CHRODIS
Dr. Teresa Bennett, HSE,
CHRODIS+ WP 5 Partner
06.06.2018
The Irish CHRODIS+ partners
CHRODIS+
Active School Flag Site Visit
Dublin, Ireland
2. Co-funded
by the Third Health Programme
of the European Union
Welcome & Introductions
Welcome to Dublin, Ireland
Aim of Site Visit
To demonstrate and share learning from the Active School Flag (ASF)
initiative as part of the CHRODIS-PLUS European Joint Action
3. Co-funded
by the Third Health Programme
of the European Union
3
Day 1: June 6th 14:00 – 17:30
Background and Policy Context to ASF
Active School Flag – How it works
Pre-implementation Planning for CHRODIS+ partners
Day 2: June 7th 08:30 – 15:30
08:30 – 12:30 Visit to Demonstration Schools (n=5)
12:30 – 13:15 Lunch
13:15 - 14:40 Review of Learning and Evidence
• Research on perceived benefits of, and barriers to,
implementation of the Active School Flag in Irish primary schools
• Discussion and feedback from School Visits and further
exploration of ASF components
14:50 – 15:30 Final Reflection and Closing
The Programme
5. CHRODIS PLUS
Joint Action
2017-2020
MEMBER STATES
STEP UP TOGETHER
TO SHARE
INNOVATIVE
PRACTICES
AND POLICIES
TO ALLEVIATE
THE BURDEN OF
CHRONIC DISEASES
42 partners representing
21 European countries
chrodis.eu
Co-funded
by the Third Health Programme
of the European Union
6. Co-funded
by the Third Health Programme
of the European Union
6
Facing the impact of chronic diseases together
The EU and chronic diseases
Reducing the burden of chronic diseases such as
diabetes, cardiovascular disease, cancer and mental disorders
is a priority for EU Member States and at the EU Policy
level, since they affect 8 out of 10 people over
the age of 65 in Europe.
A heavy price for chronic diseases
It has been estimated that chronic diseases cost
EU economies €115 billion or 0.8% of GDP
annually. Approximately 70% to 80% of healthcare
budgets across the EU are spent on treating chronic diseases.
Source: OECD publication Health at
a Glance: Europe 2016
Source: European Journal of Public
Health, Vol. 26, Supplement 1, 2016
7. Co-funded
by the Third Health Programme
of the European Union
7
The mission of the CHRODIS PLUS Joint Action
In a health-promoting Europe,
initiatives on chronic diseases should build on
FOUR PILLARS
HEALTH
PROMOTION AND
PRIMARY
PREVENTION AS A
WAY TO REDUCE
THE BURDEN OF
CHRONIC DISEASES
PATIENT
EMPOWERMENT
CONSIDERING
FUNCTIONAL
DECLINE OF THE
BODY AND A LOW
QUALITY OF LIFE AS
THE MAIN
CONSEQUENCES OF
CHRONIC DISEASES
MAKING HEALTH
SYSTEMS
SUSTAINABLE AND
RESPONSIVE TO
THE AGEING OF
OUR POPULATIONS
431 2
8. Co-funded
by the Third Health Programme
of the European Union
8
CHRODIS PLUS contributes to reducing the burden of chronic diseases in Europe by
Reaching CHRODIS PLUS objectives
IMPLEMENTING AND TESTING BEST PRACTICES, TOOLS AND POLICIES IN IMPLEMENTATION PROJECTS
SHARING THE EXPERIENCES GAINED DURING THESE IMPLEMENTATION PROJECTS ACROSS THE EU
SUPPORTING INTEGRATION INTO NATIONAL POLICIES AND SUSTAINABILITY
1
2
3
9. Co-funded
by the Third Health Programme
of the European Union
9
Countries contributing to CHRODIS PLUS
Hungary
Iceland
Ireland
Italy
Lithuania
Luxembourg
Malta
Netherlands
Poland
Portugal
Serbia
Slovakia
Slovenia
Spain
Belgium
Croatia
Finland
France
Germany
Greece
Bulgaria
10. Co-funded
by the Third Health Programme
of the European Union
Otto von Guericke University Magdeburg
Technical University of Dresden
University Hospital Regensburg
University of Ulm
Germany
10
CHRODIS PLUS beneficiaries
Belgium
Federal Public Service Health, Food Chain
Safety and Environment
Flemish Region
National Center of Public Health and
Analyses, Sophia
Bulgaria
France
The French National Cancer Institute
Greece
Aristotle University of Thessaloniki
Centre for Research and Technology
Hellas
Hungary
Semmelweis University
National Institute of Oncology
Iceland
The Directorate of Health
Italy
Local Health Services of Turin
The Foundation of the Carlo Besta
Neurological Institute, IRCCS
Superior Health Institute
Catholic University of the Sacred Heart
Malta
Ministry for Health, Government ofMalta
Poland
National Institute of Geriatrics,
Rheumatology and Rehabilitation
Lithuania
Institute of Hygiene
The Hospital of Lithuanian University of
Health Sciences Kauno Klinikos
Vilnius University
Vilnius University Hospital Santaros
Klinikos
Ireland
Netherlands
• The Dutch National Institute for Public
Health and the Environment
Portugal
Ministry of Health
Serbia
Institute of Public Health of Serbia
Faculty of Medicine, University of Belgrade
Slovakia
TheMinistryofHealthoftheSlovakRepublic
Slovenia
National Institute of Public Health
Spain
Agency for Health Quality and
Assessment of Catalonia
Regional Ministry of Health of
Andalusia
Cantabria Council of Health
Institute of Health Sciences of Aragon
International Centre of Excellence in
Chronicity Research
Institute of Health Carlos III
Europe
EuroHealthNet
European Patients’ Forum
Croatia
Croatian Institute of Public Health
Finnish Institute of Occupational Health
Technical Research Institute Finland
National Institute for Health and Welfare
Finland
Health Service Executive
Institute of Public Health
List does not include collaborating partners and pilot project implementers
11. Co-funded
by the Third Health Programme
of the European Union
11
Key CHRODIS PLUS Actors and Stakeholders
Beneficiaries
Collaborating
partners
Implementers
Governing
Board
Executive
Board
S
T
A
K
E
H
O
L
D
E
R
S
S
T
A
K
E
H
O
L
D
E
R
S
T A K E H O L D E R
T A K E H O L D E R
12. Co-funded
by the Third Health Programme
of the European Union
12
The Joint Action’s core
Implementation Projects & Policy Dialogues
• Health promotion and disease prevention: 5 practices implemented by 8 organisations
• Multimorbidity Care Model: 1 model implemented by 5 organisations
• Quality Criteria Recommendations: 1 tool implemented by 8 organisations
• Employment and Chronic Diseases: 1 tool implemented by 4 organisations
25 implementation projects in four major areas
• 15 at the national level, and 2 at the EU level
• policy dialogues contribute to informing, developing or implementing a policy
change following a round of evidence-based discussions, workshops, and
consultations on a particular subject
17 policy dialogues
13. Co-funded
by the Third Health Programme
of the European Union
Innovative
funding for
health
promotion
13
Policy dialogues at the EU level
Policy dialogues
Policy dialogues at the national level
Tobacco
control
Alcohol regulation Childhood
obesity Cancer
screening
Nutrition and
physical
activity
Inter-sectoral
collaboration
National health promotion
and prevention planning
People in
vulnerable
situations
Employment
of people
with chronic
diseases
Integrated
care
Monitoring of chronic
diseases and data
collection
Innovative financing of
health promotion
Employment and
chronic diseases
14. Co-funded
by the Third Health Programme
of the European Union
14
increase the physical activity of schoolchildren by developing a
physically active and educated school community
“Active School Flag”
Good practice from Ireland
encourage people in a town or neighbourhood to make healthy food
and exercise an easy and attractive lifestyle option for young people
in order to address obesity
“JOGG”
Good practice from the
Netherlands
promote water consumption, healthy snacking, physical activity and
the reduction of sedentary time in preschool children and their
families
“Toy Box”
Good practice from Greece
promote a healthy lifestyle through different actions and information
that targets healthy eating, smoking cessation, increased physical
activity, alcohol reduction and safe walking/biking to work
“Lombardy Workplace
Health Promotion Network”
Good practice from Italy
multicomponent training, which includes physical activity and
nutrition and health guiding to prevent health risks among older
people (71-90)
“Successful Ageing”
Good practice from Iceland
Implementation Projects
1. Health Promotion and Disease Prevention
5 projects
implemented by
8 organisations
in Europe
TO IMPROVE
NATIONAL
APPROACHES
FOR
PROMOTING
HEALTH AND
PREVENTING
DISEASES
AIM
15. Co-funded
by the Third Health Programme
of the European Union
15
Projects implemented by 5 organisations test the
Multimorbidity Care Model
Model developed by JA-CHRODIS
Sixteen components of the model are classified under five domains:
The implementation projects aim to prove the applicability of the model across
different European healthcare settings.
Implementation Projects
2. Integrated Care Model for Multimorbidity
Delivery of
Care
Decision
Support
Self
Management
Support
Information
Systems and
Technology
Social and
Community
Resources
16. Co-funded
by the Third Health Programme
of the European Union
16
Implementation Projects
3. Fostering the Quality of Care
Quality Criteria and Recommendations Tool
A tool developed by Joint Action CHRODIS (2014-2018) to improve the quality of care for
people with chronic diseases
The tool will be tested by 5 institutions as a part of CHRODIS PLUS (2017-2020)
mHealth applications
The tool will be tested by 3 institutions as a part of CHRODIS PLUS (2017-2020)
TOOL FOR DECISION-MAKERS, HEALTHCARE PROVIDERS,
PATIENTS AND HEALTHCARE PERSONNEL
TO EVALUATE AND SUPPORT THE
IMPLEMENTATION OF GOOD PRACTICES
TO IMPROVE THE QUALITY OF CARE
FOR PEOPLE WITH CHRONIC DISEASES
17. Co-funded
by the Third Health Programme
of the European Union
17
Implementation Projects
4. Employment and Chronic Diseases
The CHRODIS PLUS Training Tool for employers & the employment sector
To help employers understand the operational benefits of
- inclusion AND
- re-integration into the workplace
of people suffering from chronic diseases
The CHRODIS PLUS Toolkit for the Adaptation of the Workplace
An evidence-based, practice-oriented guide for employers to adapt their work environments to support healthy lifestyles
and prevent and manage chronic diseases in work settings
The Toolkit provides employers with support for understanding the importance of work environments + the benefits of
health promotion and chronic disease prevention, in order to promote the implementation of prevention activities for all
workers and identified high-risk groups
19. Co-funded
by the Third Health Programme
of the European Union
19
Background
Joint Action CHRODIS (2014-2017)
The JA CHRODIS results are available on the CHRODIS PLUS
website: http://chrodis.eu/outcomes-results/
Key facts about Joint Action CHRODIS
operated under the EU Health Programme
39 associated partners + 32 collaborating partners
from 25 countries
3-year duration (January 2014 – March 2017)
To identify, exchange, scale-up and transfer good
practices and effective interventions for
JA CHRODIS OBJECTIVES
multimorbidity & diabeteshealth promotion and
chronic disease prevention
The CHRODIS PLUS Joint Action builds upon the results of JA CHRODIS
20. Co-funded
by the Third Health Programme
of the European Union
Background
Joint Action CHRODIS (2014-2017)
The JA CHRODIS results are available on the CHRODIS PLUS website:
http://chrodis.eu/outcomes-results/
Key Outputs
Country Report from each Member State
Criteria to assess good practice in health promotion
3 Good Practices, highly promising and/or
evidence-based examples effective practices
identified and documented by each member state
41 Good practices documented
5 Site Visits
CHRODIS Platform for Knowledge Exchange (PKE)
To identify, exchange, scale-up and transfer good practices and
effective interventions for Health Promotion and chronic disease
prevention
WP 5 Health Promotion & Primary Prevention
21. Co-funded
by the Third Health Programme
of the European Union
21
Background
EU CHRODIS Criteria developed by an EU expert panel
Criteria name
Criteria
Weight
Category
description
1. Equity 13
2. Comprehensiveness of the intervention 12
3. Description of the practice 12
4. Ethical Considerations 11
5. Evaluation 11
6. Empowerment and Participation 10
7. Target population 9
8. Sustainability 8
9. Governance and project management 7
10. Potential of scalability and transferability 7
Criteria were developed for two purposes:
Guideline for the identification of Good Practice examples
Assessment and evaluation of practices submitted to the platform for knowledge
exchange (PKE)
22. Co-funded
by the Third Health Programme
of the European Union
Background
Joint Action CHRODIS (2014-2017)
41 Good Practices available at: http://chrodis.eu/our-work/05-health-promotion/41-good-
practices/
Ireland identified and documented 5 Good Practices
Tobacco Free
Ireland Policy
Croí
MyAction
Active School
Flag
Community
Food
Initiative
A community based cardiovascular
disease prevention programme
addressing intensive risk factor
management and lifestyle modification
Aims to enhance levels of
physical activity in children
through developing a
physically active and physically
educated school community
To promote greater access and availability
of healthy and safe food in low-income
areas through a programme of local
projects using a community development
approach.The Tobacco Free Ireland policy and allied
tobacco control programme aims to support
Ireland to be tobacco-free by 2025 through
implementation of evidence-based,
comprehensive, ambitious and integrated set of
measures
‘Let’s Take on
Childhood Obesity’
Campaign
A public health campaign to take on childhood
obesity aimed at parents of children aged 2-12 years,
on the island of Ireland.
23. Co-funded
by the Third Health Programme
of the European Union
Background
Overview of Good Practice Assessment Process
24. Co-funded
by the Third Health Programme
of the European Union
24
Background
ASF approved as a Good Practice
25. Co-funded
by the Third Health Programme
of the European Union
25
EU Best Practice Portal
EU Best Practice Portal for health promotion, disease
prevention and management of non-communicable diseases
launched 25 April, 2018
https://webgate.ec.europa.eu/dyna/bp-portal/index.cfm
One-Stop Shop
good practices
collected by actions
co-funded by the EU
Health Programme
Submission of
practices
(interventions,
projects) for
evaluation
Information portal
on projects & tools
which implement
the transfer of best
practices from one
country to others
26. Co-funded
by the Third Health Programme
of the European Union
26
Contact and follow us
Please follow us on social media to stay up to date with
the latest news on CHRODIS PLUS
o Twitter: @EU_CHRODISplus
o Facebook: EU_CHRODIS
o YouTube: EU_CHRODISplus
chrodis.eu
info@chrodis.eu
27. chrodis.eu
@EU_CHRODISplusEU_CHRODIS
CHRODIS PLUS
The Joint Action implementing good practices for chronic diseases
Thank you for your attention
This presentation is part of the CHRODIS PLUS Joint Action. This Joint Action addresses chronic diseases through cross-
national initiatives identified in JA-CHRODIS, in order to reduce the burden of chronic diseases while assuring health system
sustainability and responsiveness, under the framework of the Third Health Programme (2014-2020). The content of this
presentation is the sole responsibility of the author. Consumers, Health, Agriculture and Food Executive Agencies cannot be
held liable for any use of the information contained within this document.